Annual report pursuant to Section 13 and 15(d)

Nature of Operations and Basis of Presentation (Details)

v3.3.0.814
Nature of Operations and Basis of Presentation (Details)
May. 18, 2015
shares
Jun. 03, 2011
USD ($)
Mar. 24, 2011
USD ($)
Jul. 31, 2015
subsidiary
Nature of operations and basis of presentation        
Total purchase price     $ 3,000,000  
Number of subsidiaries | subsidiary       0
Reverse stock split ratio 0.05      
Number of fractional shares issued related to reverse stock split | shares 0      
OncoSec Medical Therapeutics        
Nature of operations and basis of presentation        
Total purchase price   $ 1,000